Frequency of epidermal growth factor receptor mutations in Bangladeshi patients with adenocarcinoma of the lung

International Journal of Clinical Oncology

Volumn 19, Issue 1, 2014, Pages 45-49

  Rahman, Shakibur ^a   Kondo, Nobuyuki ^a   Yoneda, Kazue ^a   Takuwa, Teruhisa ^a   Hashimoto, Masaki ^a   Orui, Hayato ^a   Okumura, Yoshitomo ^b   Tanaka, Fumihiro ^c   Kumamoto, Kanako ^d   Mostafa, Mohammad Golam ^e   Chowdhury, Golam Mohiuddin Akbar ^f   Haque, Akramul ^f   Hasegawa, Seiki ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b Itami City Hospital   (Japan)

^c UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^d OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e National Institute of Cancer Research and Hospital   (Bangladesh)

^f National Institute of Diseases of the Chest and Hospital (NIDCH)   (Bangladesh)

Author keywords

EGFR mutation; Epidermal growth factor receptor; Ethnic difference; Lung cancer; Single strand conformation polymorphism; Tyrosine kinase inhibitors

Indexed keywords

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BANGLADESH; BIOPSY, FINE-NEEDLE; DNA MUTATIONAL ANALYSIS; ETHNIC GROUPS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; NEOPLASM STAGING; RECEPTOR, EPIDERMAL GROWTH FACTOR; SMOKING;

EID: 84894515014     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-012-0515-4     Document Type: Article

References (17)

1. Lynch TJ, Bell DW, Sordella R, et al. (2004) Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350:2129-2139
2. Paez JG, Janne PA, Lee JC, et al. (2004) EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304:1497-1500
3. Pao W, Miller V, Zakowski M, et al. (2004) EGF receptor gene mutations are common in lung cancers from 'never smokers' and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci USA 101:13306-13311
4. Calvo E, Baselga J, et al. (2006) Ethnic differences in response to epidermal growth factor receptor tyrosinekinase inhibitors. J Clin Oncol 24:2158-2163
5. Eberhard DA, Johnson BE, Amler LC, et al. (2005) Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib. J Clin Oncol 23:5900-5909
6. Bell DW, Lynch TJ, Haserlat SM, et al. (2005) Epidermal growth factor receptor mutations and gene amplification in nonsmall-cell lung cancer: molecular analysis of the IDEAL/INTACT gefitinib trials. J Clin Oncol 23:8081-8092
7. Mok TS, Wu YL, Thongprasert S, et al. (2009) Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med 361:947-957
8. Travis WD, Colby TV, Corrin B, et al. (1999) World Health Organization International Histological Classification of Tumors. Histological typing of lung and pleural tumors, 3rd edn. Springer, New York
9. Leidner RS, Fu P, Clifford B, et al. (2009) Genetic abnormalities of the EGFR pathway in African American patients with non-small-cell lung cancer. J Clin Oncol 33:5620-5626
10. Al-Kuraya K, Siraj AK, Bavi P, et al. (2006) High epidermal growth factor receptor amplification rate but low mutation frequency in Middle East lung cancer population. Hum Pathol 37:453-457
11. Marchetti A, Martella C, Felicioni L, et al. (2005) EGFR mutations in non-small cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment. J Clin Oncol 23:857-865
12. Yang SH, Mechanic LE, Yang P, et al. (2005) Mutations in the tyrosine kinase domein of the epidermal growth factor receptor in non-small cell lung cancer. Clin Cancer Res 11:2106-2110
13. Huang SF, Liu HP, Li LH, et al. (2004) High frequency of epidermal growth factor receptor mutations with complex patterns in non-small cell lung cancers related to gefitinib responsiveness in Taiwan. Clin Cancer Res 10:8195-8203
14. Sonobe M, Manabe T, Wada H, et al. (2005) Mutations in the epidermal growth factor receptor gene are linked to smoking-independent, lung adenocarcinoma. Br J Cancer 93:355-363
15. Kosaka T, Yatabe Y, Endoh H, et al. (2004) Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications. Cancer Res 64:8919-8923
16. Han SW, Kim TY, Hwang PG, et al. (2005) Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib. J Clin Oncol 23:2493-2501
17. Sahoo R, Harini VV, Babu VC, et al. (2011) Screening for EGFR mutations in lung cancer. A report from India. Lung Cancer 73:316-319